-
hcup-us.ahrq.gov/toolssoftware/surgeryflags_svcproc/SurgeryFlags_Services_Procedures_v2024-1/SF-SvcProc-User-Guide-v2024-1.pdf
July 01, 2024 - that involve a major
intervention such as percutaneous transluminal coronary angioplasty (PTCA), vascular
-
hcup-us.ahrq.gov/toolssoftware/surgeryflags_svcproc/SF-SvcProc-User-Guide-v2023-1.pdf
February 01, 2024 - that involve a major
intervention such as percutaneous transluminal coronary angioplasty (PTCA), vascular
-
hcup-us.ahrq.gov/datainnovations/clinicaldata/AppendixEAHRQProjectDetails.pdf
January 15, 2008 - respiratory
inflammation (490, 491 series, 494), chronic lung disease (493.2, 496, 500 - 505),
peripheral vascular
-
hcup-us.ahrq.gov/toolssoftware/surgeryflags_svcproc/SF-SvcProc-User-Guide-v2025-1.pdf
June 01, 2025 - that involve a major
intervention such as percutaneous transluminal coronary angioplasty (PTCA), vascular
-
www.ahrq.gov/ncepcr/tools/workforce-financing/case-example-3.html
July 01, 2019 - ); resolution of problems; and specific quality measures such as for asthma, diabetes, and ischemic vascular
-
www.ahrq.gov/hai/tools/surgery/modules/implementation/opt-briefings-fac-notes.html
December 01, 2017 - For instance, any comments collected regarding the vascular surgical team are filtered and shared with
-
www.ahrq.gov/sites/default/files/wysiwyg/takeheart/training/module-6-implementation-guide.pdf
June 02, 2025 - • Genesis HealthCare System—Welcome to Heart & Vascular and Pulmonary Rehabilitation
PowerPoint for
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/003-ss-antimicrobial-prophylaxis-part-2-fg.docx
April 01, 2025 - Surgeries included non-spine orthopedic, spine orthopedic, cardiac, and vascular.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/inevidup.pdf
September 01, 2009 - Recommendations for Adults: Heart and Vascular Diseases: Screening for
Miettinen OS.
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Pratt.pdf
March 01, 2004 - The UCSD
Office of Learning Resources then contributed an Immersion Medical CathSim™
VR vascular access
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - for an extended time can
damage blood vessels, leading to retinopathy and nephropathy, peripheral vascular … the
Value Set Authority Center to express CVD “conditions” (e.g., myocardial infarction, ischemic vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
March 08, 2012 - Histamine stimulation of the
histamine-1 (H1) receptors on sensory nerves causes vascular dilation and … Leukotrienes also increase vascular
permeability.
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2005.jsp
January 01, 2005 - Deficiency anemias
CM_ARTH
2002-2005
AHRQ comorbidity measure: Rheumatoid arthritis/collagen vascular … comorbidity measure: Paralysis
CM_PERIVASC
2002-2005
AHRQ comorbidity measure: Peripheral vascular
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2004.jsp
January 01, 2004 - Deficiency anemias
CM_ARTH
2002-2004
AHRQ comorbidity measure: Rheumatoid arthritis/collagen vascular … comorbidity measure: Paralysis
CM_PERIVASC
2002-2004
AHRQ comorbidity measure: Peripheral vascular
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2003_v7.jsp
January 01, 2003 - Deficiency anemias
PA
CM_ARTH
2002-2003
AHRQ comorbidity measure: Rheumatoid arthritis/collagen vascular … comorbidity measure: Paralysis
PA
CM_PERIVASC
2002-2003
AHRQ comorbidity measure: Peripheral vascular
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
November 01, 2013 - Vascular events in the
Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient
characteristics … Year-by-year analysis of cardio-
vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE
-
hcup-us.ahrq.gov/reports/methods/2006_4.pdf
January 01, 2006 - 18 Utilization Flags
Cardiac Stress Test
A cardiac stress test is used to evaluate the heart and vascular … It is also indicated for use in
patients scheduled to undergo elective, non-cardiac, non-vascular surgery
-
www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
July 15, 2008 - Is C-reactive protein specific for vascular disease in women? Ann Intern Med . 2002;136:529-33. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
October 01, 2010 - • There were 7 CVA/TIA, 11 vascular injuries, 1 PV stenosis,
1 mitral valve injury, and 1 complete … There were 6 CVA/TIA, 12 tamponade, 1 atrioesophageal
fistula, 6 pulmonary vein stenosis, and 14 vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
January 01, 2010 - inspiratory flow (and hence nasal
patency); in contrast, nasal congestion, as a result of nasal edema and vascular … The reaction may include
rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic